World’s Largest Free Retina Image Gallery & Reference Library

Retina Rocks, the image bank of the Retina World Congress, is a free, open-source online image library whose mission is to help educate the world’s eye care providers about why the retina rocks!

Image Gallery   Over 51,000 multimodal images
Reference Library   Over 14,000 annotated citations from the major eye journals
Cases Atlas   Over 1,600 case studies organized by disease entity
Instagram   Access our Instagram feed @retina.rocks
Wall of Fame   Look here for the best submitted cases and images
Merch   The PERFECT gift for every member of the family!
 

 

Case of the Day

Have a comment or question about today's case? Go to your favorite social media platform to join the conversation!

MALIGNANT HYPERTENSION WITH EXUDATIVE RETINAL DETACHMENT

Sherina Thomas, Vaishnavi Rao, Rachel Gonsalves, Meghana Panchakshari and Harshita Khetan

This 26YO male presented with a 3-day history of headache and vision loss in his left eye. He had a known history of hypertension (HTN) and admitted to not taking his medication regularly. Vision was 20/20 OD and CF 6 feet OS.

Fundus photography shows widespread confluent yellowish choroidal lesions and multifocal, variably confluent exudative detachments extending into each midperiphery, with an inferior exudative retinal detachment OS. Bilateral findings include optic nerve swelling, attenuated vessels, and nasal macular lipid. Blood pressure was 220/180 mmHg. He was admitted to the emergency ward, and antihypertensives were initiated. Chronic renal failure was diagnosed, and hemodialysis was initiated.

Two weeks later, our patient’s optic nerve swelling and exudative retinal detachment resolved. Vision improved to 20/100 OS (image 3).

Learning Points:
Malignant hypertension, defined as blood pressure above 180 systolic and/or 120 diastolic, is a life-threatening medical emergency. Eye doctors are uniquely positioned to diagnose this condition. Patients will often present with bilateral optic nerve swelling, flame-shaped retinal hemorrhages, and, with more chronic disease, lipid precipitates in the nasal macular outer plexiform layer.

Hypertensive chorioretinopathy commonly occurs in younger patients with acute elevation of blood pressure and is usually associated with conditions such as malignant hypertension, pre-eclampsia and renal failure (Kon et al, Acta Ophthalmologica 2008;86:227–228). With blood pressure control, these resolve often with minimal funduscopic changes. More severe disease may cause focal (Elschnig spots) or linear (Siegrist streaks) choroidal pigmentary changes. The acute findings are felt to be caused by choroidal arterial constriction with secondary choriocapillaris necrosis (Hayreh et al, Ophthalmology 1986;93:1383-1400). This causes ischemic injury to the overlying RPE with a breakdown of the outer blood-retinal barrier and exudative subretinal fluid.

 

Article of the Day

Improvement in visual outcomes in diabetic macular edema through the reduction of macular thickness fluctuations using the 0, 19 mg fluocinolone acetonide implant

Penas S, Pessoa B, Teixeira C, Ruão M, Sousa JPC, Carneiro Â, Silva R, Meireles A

Int Ophthalmol. 2026 Sep 24;46(1):402. doi: 10.1007/s10792-026-04262-w.

Summary

Iluvien for unresponsive or recurrent DME: Reduced retinal thickness fluctuations with better VA — RIVER study, Retrospective, Portuguese national registry, 97 eyes

Abstract

Purpose: This study aimed to assess the effectiveness of 0.19-mg fluocinolone acetonide intravitreal (FAc) implant to control retinal thickness fluctuations (RTF) in diabetic macular edema (DME) and its effect on best-corrected visual acuity (BCVA).

Methods: The RIVER study was a multicenter, retrospective, non-interventional study analyzing data of the Retina.pt portuguese national registry in DME. Retinal thickness was assessed using the spectral domain optical coherence tomography (SD-OCT). The primary endpoint was the assessment of RTF along the follow-up, through the combined measurement of retinal thickness amplitude (RTA), retinal thickness standard deviation (RTSD), and central subfield thickness area under the curve (CST-AUC). Eyes were stratified into quartiles (Q) and median-split according to these variables.

Results: The mean follow-up time after the FAc implantation was 82 ± 26, 96 months. From baseline to last follow-up visit after the implant, mean RTA decreased from 187.6±150.4 to 151.6±126.4 µm (p=0.1204), mean RTSD significantly reduced from 96.3±78.1 to 60.8±57.3 µm (p=0.0032) and mean CST-AUC significantly reduced from 446 to 349 µm (p<0.0001). BCVA significantly improved in eyes with RTA Q1, Q2, Q3 (p<0.05); eyes with RTSD Q1, Q2, and Q3 (p<0.05); and eyes with CST-AUC Q1, Q2, and Q3 (p<0.05). According to the median split, eyes with RTA and RTSD < to median showed greater BCVA improvement.

Conclusions: Retinal thickness fluctuation was significantly reduced after the Fc implant. Moreover, a lower retinal thickness variability tended to be associated with better visual outcomes.

Download Article

Affiliate Societies

Optomap
Retina Rocks